![The IFN-γ–p38, ERK kinase axis exacerbates neutrophilic chronic rhinosinusitis by inducing the epithelial-to-mesenchymal transition | Mucosal Immunology The IFN-γ–p38, ERK kinase axis exacerbates neutrophilic chronic rhinosinusitis by inducing the epithelial-to-mesenchymal transition | Mucosal Immunology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41385-019-0149-1/MediaObjects/41385_2019_149_Fig1_HTML.png)
The IFN-γ–p38, ERK kinase axis exacerbates neutrophilic chronic rhinosinusitis by inducing the epithelial-to-mesenchymal transition | Mucosal Immunology
![Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml (Paquete de 2) : Amazon.es: Bebé Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml (Paquete de 2) : Amazon.es: Bebé](https://m.media-amazon.com/images/I/21N8vaeyzEL._AC_UF1000,1000_QL80_.jpg)
Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml (Paquete de 2) : Amazon.es: Bebé
![Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/d6219c58-2385-4eea-93ff-0243ce87d824/gr1.gif)
Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial - The Lancet Respiratory Medicine
![Early COVID-19 responses in the nose and throat predict disease severity - Boston Children's Answers Early COVID-19 responses in the nose and throat predict disease severity - Boston Children's Answers](https://answers.childrenshospital.org/wp-content/uploads/2021/07/covid_nose.jpg)
Early COVID-19 responses in the nose and throat predict disease severity - Boston Children's Answers
![Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml : Amazon.es: Bebé Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml : Amazon.es: Bebé](https://m.media-amazon.com/images/I/81kQbyogqKL.jpg)
Rhinomer Spray Nasal Descongestionante Intenso Eucalipto, Para Adultos y Niños a Partir de 6 Años, 20 ml : Amazon.es: Bebé
![Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial | News Center | Stanford Medicine Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial | News Center | Stanford Medicine](https://med.stanford.edu/content/dam/sm-news/images/2023/02/omicron.jpg)
Single drug injection wards off COVID-19 hospitalizations, in Stanford Medicine-led trial | News Center | Stanford Medicine
![Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis: Molecular Therapy - Nucleic Acids Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/asset/bd374f78-c346-40b8-8e76-df356fa81269/fx1.jpg)
Transient Transfection of the Respiratory Epithelium with Gamma Interferon for Host-Directed Therapy in Pulmonary Tuberculosis: Molecular Therapy - Nucleic Acids
![Frontiers | Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study Frontiers | Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study](https://www.frontiersin.org/files/MyHome%20Article%20Library/967716/967716_Thumb_400.jpg)
Frontiers | Interferon α-2b spray shortened viral shedding time of SARS-CoV-2 Omicron variant: An open prospective cohort study
Interferon-α-2b Nasal Spray for Treating SARS-CoV-2 Omicron Variant-Infected Children,Journal of Clinical Immunology - X-MOL
![IJMS | Free Full-Text | Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience IJMS | Free Full-Text | Therapeutic Effectiveness of Interferon-α2b against COVID-19 with Community-Acquired Pneumonia: The Ukrainian Experience](https://www.mdpi.com/ijms/ijms-24-06887/article_deploy/html/images/ijms-24-06887-g001.png)